Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Tetrabenazine for hyperglycemic‐induced hemichorea–hemiballismus

Identifieur interne : 003153 ( Main/Exploration ); précédent : 003152; suivant : 003154

Tetrabenazine for hyperglycemic‐induced hemichorea–hemiballismus

Auteurs : Oraporn Sitburana [États-Unis] ; William G. Ondo [États-Unis]

Source :

RBID : ISTEX:399EC0F723477E0F85A05D21F94DB2B0E4E07E8A

Descripteurs français

English descriptors

Abstract

We reported a 74‐year‐old woman with new‐onset diabetes mellitus who presented with the sudden onset of mild left hemiparesis and marked left hemichorea–hemiballismus. Brain CT scan and MRI showed T1W, T2W, and DWI lesions in the right putamen and caudate, which have been previously reported in cases of hyperglycemic‐induced hemichorea–hemiballismus (HIHH). The patient dramatically responded to tetrabenazine within a day. Subsequent dose reductions lead to a reemergence of symptoms. Tetrabenazine improves a variety of hyperkinetic movement disorders but, to our knowledge, its use has never been reported for HIHH. © 2006 Movement Disorder Society

Url:
DOI: 10.1002/mds.21100


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Tetrabenazine for hyperglycemic‐induced hemichorea–hemiballismus</title>
<author>
<name sortKey="Sitburana, Oraporn" sort="Sitburana, Oraporn" uniqKey="Sitburana O" first="Oraporn" last="Sitburana">Oraporn Sitburana</name>
</author>
<author>
<name sortKey="Ondo, William G" sort="Ondo, William G" uniqKey="Ondo W" first="William G." last="Ondo">William G. Ondo</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:399EC0F723477E0F85A05D21F94DB2B0E4E07E8A</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1002/mds.21100</idno>
<idno type="url">https://api.istex.fr/document/399EC0F723477E0F85A05D21F94DB2B0E4E07E8A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003753</idno>
<idno type="wicri:Area/Istex/Curation">003753</idno>
<idno type="wicri:Area/Istex/Checkpoint">001C12</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Sitburana O:tetrabenazine:for:hyperglycemic</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16986158</idno>
<idno type="wicri:Area/PubMed/Corpus">002A89</idno>
<idno type="wicri:Area/PubMed/Curation">002A89</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A59</idno>
<idno type="wicri:Area/Ncbi/Merge">001850</idno>
<idno type="wicri:Area/Ncbi/Curation">001850</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001850</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Sitburana O:tetrabenazine:for:hyperglycemic</idno>
<idno type="wicri:Area/Main/Merge">004466</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:07-0021742</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001889</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001432</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001871</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Sitburana O:tetrabenazine:for:hyperglycemic</idno>
<idno type="wicri:Area/Main/Merge">004966</idno>
<idno type="wicri:Area/Main/Curation">003153</idno>
<idno type="wicri:Area/Main/Exploration">003153</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Tetrabenazine for hyperglycemic‐induced hemichorea–hemiballismus</title>
<author>
<name sortKey="Sitburana, Oraporn" sort="Sitburana, Oraporn" uniqKey="Sitburana O" first="Oraporn" last="Sitburana">Oraporn Sitburana</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ondo, William G" sort="Ondo, William G" uniqKey="Ondo W" first="William G." last="Ondo">William G. Ondo</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2006-11">2006-11</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="2023">2023</biblScope>
<biblScope unit="page" to="2025">2025</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">399EC0F723477E0F85A05D21F94DB2B0E4E07E8A</idno>
<idno type="DOI">10.1002/mds.21100</idno>
<idno type="ArticleID">MDS21100</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Anti-Dyskinesia Agents (therapeutic use)</term>
<term>Chorea</term>
<term>Chorea (drug therapy)</term>
<term>Chorea (etiology)</term>
<term>Chorea (pathology)</term>
<term>Dyskinesias (drug therapy)</term>
<term>Dyskinesias (etiology)</term>
<term>Dyskinesias (pathology)</term>
<term>Female</term>
<term>Functional Laterality (drug effects)</term>
<term>Hemiballismus</term>
<term>Humans</term>
<term>Hyperglycemia</term>
<term>Hyperglycemia (complications)</term>
<term>Hyperglycemia (pathology)</term>
<term>Magnetic Resonance Imaging (methods)</term>
<term>Nervous system diseases</term>
<term>Tetrabenazine</term>
<term>Tetrabenazine (therapeutic use)</term>
<term>ballismus</term>
<term>chorea</term>
<term>hyperglycemia</term>
<term>tetrabenazine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Anti-Dyskinesia Agents</term>
<term>Tetrabenazine</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Hyperglycemia</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Functional Laterality</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Chorea</term>
<term>Dyskinesias</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Chorea</term>
<term>Dyskinesias</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Magnetic Resonance Imaging</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Chorea</term>
<term>Dyskinesias</term>
<term>Hyperglycemia</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Chorée syndrome</term>
<term>Hyperglycémie</term>
<term>Hémiballisme</term>
<term>Système nerveux pathologie</term>
<term>Tétrabénazine</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We reported a 74‐year‐old woman with new‐onset diabetes mellitus who presented with the sudden onset of mild left hemiparesis and marked left hemichorea–hemiballismus. Brain CT scan and MRI showed T1W, T2W, and DWI lesions in the right putamen and caudate, which have been previously reported in cases of hyperglycemic‐induced hemichorea–hemiballismus (HIHH). The patient dramatically responded to tetrabenazine within a day. Subsequent dose reductions lead to a reemergence of symptoms. Tetrabenazine improves a variety of hyperkinetic movement disorders but, to our knowledge, its use has never been reported for HIHH. © 2006 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Texas</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Sitburana, Oraporn" sort="Sitburana, Oraporn" uniqKey="Sitburana O" first="Oraporn" last="Sitburana">Oraporn Sitburana</name>
</region>
<name sortKey="Ondo, William G" sort="Ondo, William G" uniqKey="Ondo W" first="William G." last="Ondo">William G. Ondo</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003153 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003153 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:399EC0F723477E0F85A05D21F94DB2B0E4E07E8A
   |texte=   Tetrabenazine for hyperglycemic‐induced hemichorea–hemiballismus
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024